EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer

Evangelia-Alexandra Salvanou iD, Adamantia Apostolopoulou, Stavros Xanthopoulos, Stuart Koelewijn, Philippe van Overeem, Gautier Laurent iD, Rana Bazzi, Franck Denat iD, Stéphane Roux iD, Penelope Bouziotis iD

Materials · 08.01.2025 · 18 (2) · 248

DOI: 10.3390/ma18020248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Materials, online erschienen am 08.01.2025. Verfasst von Evangelia-Alexandra Salvanou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Radiochemical Studies Laboratory, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to their intriguing emission profile, Terbium-161 (161Tb) radiopharmaceuticals seem to bring significant advancement in theranostic applications to cancer treatment. The combination of 161Tb with nanoscale brachytherapy as an approach for cancer treatment is particularly advantageous and promising. Herein, we propose the application of a hybrid nanosystem comprising gold decorated (Au@TADOTAGA) iron oxide nanoflowers as a form of injectable nanobrachytherapy for the local treatment of breast cancer. More specifically, Au@TADOTAGA and NFAu@TADOTAGA NPs were efficiently radiolabeled with 161Tb, and their in vitro stability was assessed up to 21 d post-radiolabeling. Furthermore, their cytotoxic profile against 4T1 breast cancer cells was evaluated, and their ex vivo biodistribution characteristics were revealed after intratumoral injection in the same animal model. The enhanced retention at the tumor site urged us to evaluate the therapeutic effect of the [161Tb]Tb-NFAu@TADOTAGA nanosystem after intratumoral administration to 4T1-tumor-bearing mice, over a period of 24 days. Three different therapeutic protocols were performed in order to identify which therapeutic approach would offer the optimum results and identify the proposed nanosystem as a promising nanoscale brachytherapy agent.

Schlagwörter

Stichwörter der Autor:innen

MTTTerbium-161biodistributionbreast cancergold nanoparticlesnanoscale brachytherapyradiolabelingtherapeutic efficacy

Autor:innen und Institutionen

  • Radiochemical Studies Laboratory, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research "Demokritos", Patriarchou Grigoriou and 27 Neapoleos Street, 15341 At…
  • Terthera b.v., Minervum 7070, 4817 ZK Breda, The Netherlands.
  • Laboratoire Chrono-Environnement, Université de Franche-Comté, CNRS, F-25000 Besançon, France.
  • Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université de Bourgogne, F-21078 Dijon, France.

ORCID-Profile: Evangelia-Alexandra Salvanou, Gautier Laurent, Franck Denat, Stéphane Roux, Penelope Bouziotis

Zitieren

APA

Salvanou, E. A., Apostolopoulou, A., Xanthopoulos, S., Koelewijn, S., van Overeem, P., Laurent, G., Bazzi, R., Denat, F., Roux, S., & Bouziotis, P. (2025). 161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer. Materials, 18(2), 248. https://doi.org/10.3390/ma18020248

Vancouver

Salvanou EA, Apostolopoulou A, Xanthopoulos S, Koelewijn S, van Overeem P, Laurent G, et al. 161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer. Materials. 2025;18(2):248. doi:10.3390/ma18020248

BibTeX
@article{Salvanou2025,
  author = {Salvanou, Evangelia-Alexandra and Apostolopoulou, Adamantia and Xanthopoulos, Stavros and Koelewijn, Stuart and van Overeem, Philippe and Laurent, Gautier and Bazzi, Rana and Denat, Franck and Roux, Stéphane and Bouziotis, Penelope},
  title = {161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer},
  journal = {Materials},
  year = {2025},
  volume = {18},
  number = {2},
  pages = {248},
  doi = {10.3390/ma18020248}
}
Kostenlos starten →